Home » Topics » Regulatory

Regulatory
RSS

Nabi submits supplemental data for Nabi-HB Intravenous BLA

Sep. 2, 2003

Once-daily Cipro XR approved for treatment of cUTIs

Sep. 2, 2003

Phase I/II trials cleared for topical PTH (7-34) in chemotherapy-induced alopecia

Aug. 26, 2003

Levitra receives FDA approval

Aug. 25, 2003

Health Canada approves Gamunex

Aug. 22, 2003

FDA approves Trileptal for children

Aug. 13, 2003

Lapdap approved by U.K. agency for treatment of P. falciparum malaria

Aug. 11, 2003

FDA approves Photofrin PDT for high-grade dysplasia in Barrett's esophagus

Aug. 6, 2003

Enbrel approved to improve physical function in RA patients

Aug. 5, 2003

Combination therapies for allergic diseases comprising an anti-IgE antibody and antiallergic agent

Aug. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.